Ferritin is a protein complex composed of two chains, light (FTL) and heavy (FTH), and its clinical importance has been demonstrated in many cancers through multiple roles: the contribution to tumorigenesis, the restoration of tumor-dependent vessel growth, and the association with tissue invasion (Schonberg, 2015; Aversa et al., 2017). The gene discussed is FTH1; the disease is cancer.